August 17, 2017 4:28 AM ET


Company Overview of Spring Bank Pharmaceuticals, Inc.

Executive Profile

Martin J. Driscoll

Chairman, Chief Executive Officer and President, Spring Bank Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2016


Mr. Martin J. Driscoll, also known as Marty, has been the Chief Executive Officer and President at Spring Bank Pharmaceuticals, Inc. since August 17, 2015. Mr. Driscoll has been a Principal of MJD Consulting LLC since 2005 and was its Principal from 2002 to 2003. He served as the Chief Executive Officer of Asmacure Ltée from November 2010 to July 2015 and served as its President since November 2010. He co-founded Pear Tree Pharmaceuticals Inc. in 2007. He served as the ...

Corporate Headquarters

86 South Street
Hopkinton, Massachusetts 01748

United States

Phone: 508-473-5993
Fax: 508-381-0347

Board Members Memberships

Chairman of The Board
Chairman, Chief Executive Officer and President


The University of Texas System

Other Affiliations

Annual Compensation

Total Annual Compensation$593,331

Stocks Options

All Other Compensation$10,600
Exercisable Options$98,349
Unexercisable Options$216,698
Total Number of Options$315,047

Total Compensation

Total Annual Cash Compensation$603,931
Total Short Term Compensation$593,331
Other Long Term Compensation$10,600
Total Calculated Compensation$751,615

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Spring Bank Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at